Fingerprint
Dive into the research topics of 'Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically